*КОЕ – колониеобразующая единица (показатель количества жизнеспособных микроорганизмов)
1. Martoni CJ , Evans M, Chow CT, Luisa S Chan LS, Leyer G, Impact of a probiotic product on bowel habits and microbial profile in participants with functional constipation: a randomized controlled trial, J Dig Dis. 2019
2.Gerasimov SV, Vasjuta V, Myhovych O, Bondarchuk I, Probiotic Supplement Reduces Atopic Dermatitis in Preschool Children: a randomized, double-blind, placebo-controlled, clinical trial, J Clin Dermatol. 2010
3. Gerasimov SV, Ivantsiv VA, Bobryk LM, Tsitsura OO, Dedyshin LP, Guta NV, Yandyo BV, Role of short-term use of L. acidophilus DDS-1 and B. lactis UABLA-12 in acute respiratory infections in children: a randomized controlled trial, Eur J Clin Nutr. 2016
4. Martoni CJ, Srivastava S, Leyer GJ, Nutrients. 2020 12, 363
5. Pakdaman MN, Udani JK, Molina JP, Shahani M, The effects of the DDS-1 strain of lactobacillus on symptomatic relief for lactose intolerance: a randomized, double-blind, placebo-controlled, crossover clinical trial, Nutr J. 2016
6. Martoni CJ, Srivastava S, Leyer GJ, Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 Improve Abdominal Pain Severity and Symptomology in Irritable Bowel Syndrome: a randomized Controlled Trial, Nutrients. 2020
7. Gan D, Chen J, Tang X, Xiao L, Martoni CJ, Leyer G, Huang G, Li W, Impact of a probiotic chewable tablet on stool habits and microbial profile in children with functional constipation: a randomized controlled clinical trial, Front Microbiol. 2022